Hughes, D.; Prestle, J.; Zippel, N.; McFetridge, S.; Szczepan, M.; Neubauer, H.; Xu, H.; Chen, M.
Nintedanib Induces Mesenchymal-to-Epithelial Transition and Reduces Subretinal Fibrosis Through Metabolic Reprogramming. Int. J. Mol. Sci. 2025, 26, 7131.
https://doi.org/10.3390/ijms26157131
AMA Style
Hughes D, Prestle J, Zippel N, McFetridge S, Szczepan M, Neubauer H, Xu H, Chen M.
Nintedanib Induces Mesenchymal-to-Epithelial Transition and Reduces Subretinal Fibrosis Through Metabolic Reprogramming. International Journal of Molecular Sciences. 2025; 26(15):7131.
https://doi.org/10.3390/ijms26157131
Chicago/Turabian Style
Hughes, David, Jüergen Prestle, Nina Zippel, Sarah McFetridge, Manon Szczepan, Heike Neubauer, Heping Xu, and Mei Chen.
2025. "Nintedanib Induces Mesenchymal-to-Epithelial Transition and Reduces Subretinal Fibrosis Through Metabolic Reprogramming" International Journal of Molecular Sciences 26, no. 15: 7131.
https://doi.org/10.3390/ijms26157131
APA Style
Hughes, D., Prestle, J., Zippel, N., McFetridge, S., Szczepan, M., Neubauer, H., Xu, H., & Chen, M.
(2025). Nintedanib Induces Mesenchymal-to-Epithelial Transition and Reduces Subretinal Fibrosis Through Metabolic Reprogramming. International Journal of Molecular Sciences, 26(15), 7131.
https://doi.org/10.3390/ijms26157131
